Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
128,000
Total Value
$2,629,975.10
P&L
+inf% (+$3,416,320.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 13, 2026 | Grant/Award | 64,000 | $0.00 | $0.00 | 496,886 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Sale | 56,815 | $41.01 | $2,329,983.15 | 440,071 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Sale | 7,165 | $41.75 | $299,138.75 | 432,906 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 15, 2026 | Sale | 20 | $42.66 | $853.20 | 432,886 | Direct | โ | View Details |